An HJ - Search Results

1

A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.

Lee J, Park S, Jung HA, Lee SH, Seo S, Kim SB, Kim JW, Lee KW, Kang EJ, Kim JW, Choi YJ, Shim BY, An HJ, Park LC, Shin SH, Kim JJ, Oh SY, Kim MK, Ahn MJ. Lee J, et al. Among authors: an hj. Cancer. 2023 Oct 1;129(19):2966-2974. doi: 10.1002/cncr.34892. Epub 2023 May 28. Cancer. 2023. PMID: 37246414 Clinical Trial.

2

Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).

Kim Y, Lee SJ, Lee JY, Lee SH, Sun JM, Park K, An HJ, Cho JY, Kang EJ, Lee HY, Kim J, Keam B, Kim HR, Lee KE, Choi MY, Lee KH, Ahn MJ. Kim Y, et al. Among authors: an hj. Cancer. 2017 Jun 1;123(11):1958-1964. doi: 10.1002/cncr.30537. Epub 2017 Jan 19. Cancer. 2017. PMID: 28102887 Free article. Clinical Trial.

3

Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer.

An HJ, Jeon HJ, Chun SH, Jung HA, Ahn HK, Lee KH, Kim MH, Kim JH, Cheon J, Kim J, Koh SJ. An HJ, et al. Cancer Res Treat. 2019 Oct;51(4):1632-1638. doi: 10.4143/crt.2019.009. Epub 2019 Apr 18. Cancer Res Treat. 2019. PMID: 30999720 Free PMC article.

4

Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial.

Lee GW, Go SI, Kim DW, Kim HG, Kim JH, An HJ, Jang JS, Kim BS, Hahn S, Heo DS. Lee GW, et al. Among authors: an hj. Thorac Cancer. 2020 Jan;11(1):62-71. doi: 10.1111/1759-7714.13229. Epub 2019 Nov 10. Thorac Cancer. 2020. PMID: 31707767 Free PMC article. Clinical Trial.

5

Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09).

Cho JH, Lim SH, An HJ, Kim KH, Park KU, Kang EJ, Choi YH, Ahn MS, Lee MH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Cho JH, et al. Among authors: an hj. J Clin Oncol. 2020 Feb 10;38(5):488-495. doi: 10.1200/JCO.19.00931. Epub 2019 Dec 11. J Clin Oncol. 2020. PMID: 31825714 Free PMC article. Clinical Trial.

6

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea.

Lim SM, Kim SW, Cho BC, Kang JH, Ahn MJ, Kim DW, Kim YC, Lee JS, Lee JS, Lee SY, Park KU, An HJ, Cho EK, Jang TW, Kim BS, Kim JH, Lee SS, Na II, Yoo SS, Lee KH. Lim SM, et al. Among authors: an hj. Cancer Res Treat. 2020 Oct;52(4):1112-1119. doi: 10.4143/crt.2020.245. Epub 2020 May 15. Cancer Res Treat. 2020. PMID: 32599984 Free PMC article.

7

Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12.

Park JH, Chun SH, Lee YG, Chang H, Lee KW, Kim HR, Shin SH, An HJ, Lee KE, Hwang IG, Ahn MJ, Kim SB, Keam B. Park JH, et al. Among authors: an hj. J Cancer Res Clin Oncol. 2020 Dec;146(12):3359-3369. doi: 10.1007/s00432-020-03316-5. Epub 2020 Jul 15. J Cancer Res Clin Oncol. 2020. PMID: 32671504

8

Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12.

Park JH, Chun SH, Lee YG, Chang H, Lee KW, Kim HR, Shin SH, An HJ, Lee KE, Hwang IG, Ahn MJ, Kim SB, Keam B. Park JH, et al. Among authors: an hj. J Cancer Res Clin Oncol. 2020 Dec;146(12):3371. doi: 10.1007/s00432-020-03342-3. J Cancer Res Clin Oncol. 2020. PMID: 32852636

9

A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer.

Kang JH, Lee KH, Kim DW, Kim SW, Kim HR, Kim JH, Choi JH, An HJ, Kim JS, Jang JS, Kim BS, Kim HT. Kang JH, et al. Among authors: an hj. Br J Cancer. 2021 Feb;124(4):713-720. doi: 10.1038/s41416-020-01055-5. Epub 2020 Nov 16. Br J Cancer. 2021. PMID: 33191408 Free PMC article. Clinical Trial.

10

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12.

Lee YG, Chang H, Keam B, Chun SH, Park J, Park KU, Shin SH, An HJ, Lee KE, Lee KW, Kim HR, Kim SB, Ahn MJ, Hwang IG. Lee YG, et al. Among authors: an hj. Cancer Res Treat. 2021 Jul;53(3):671-677. doi: 10.4143/crt.2020.824. Epub 2020 Dec 7. Cancer Res Treat. 2021. PMID: 33285051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

758 results

Search Page